Latest News about MRK
Recent news which mentions MRK
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
September 09, 2024
From Benzinga
3 No-Brainer Dividend Stocks to Buy in September
September 08, 2024
From Motley Fool
What's Going On With Merck Shares Thursday?
September 05, 2024
From Benzinga
Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?
September 05, 2024
From Motley Fool
The Smartest Dividend Stocks to Buy With $5,000 Right Now
September 05, 2024
From Motley Fool
Merck's Death Cross Vs. Gilead's Golden Cross: Pharma Giants Diverge On Wall Street
September 03, 2024
From Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
From Benzinga
2 Dividend Stocks You Can Safely Hold Through a Recession
September 02, 2024
From Motley Fool
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
August 29, 2024
From Benzinga
From Benzinga
12 Dividend Stocks to Earn Income Every Month
August 28, 2024
From Motley Fool
From Benzinga
3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
August 27, 2024
From Motley Fool
Merck & Co's Options: A Look at What the Big Money is Thinking
August 26, 2024
Tickers
MRK
From Benzinga
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer
August 23, 2024
From Benzinga
From Benzinga
Merck & Co's Options: A Look at What the Big Money is Thinking
August 19, 2024
Tickers
MRK
From Benzinga
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
August 18, 2024
From Motley Fool
From Benzinga
2 Dow Jones Stocks to Buy Hand Over Fist Right Now
August 15, 2024
From Motley Fool
From Benzinga
From InvestorPlace
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
From Benzinga
Merck's $1.3B Deal For Potential Autoimmune Disorder Candidate Is Relevant To Cullinan's Investigational Drug, Says Analyst
August 09, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.